Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY; Group for the Respect of Excellence and Ethics in Science. Abadie E, et al. Among authors: ethgen d. Osteoarthritis Cartilage. 2004 Apr;12(4):263-8. doi: 10.1016/j.joca.2004.01.006. Osteoarthritis Cartilage. 2004. PMID: 15023377 Free article. Review.
Adherence to treatment of osteoporosis: a need for study.
Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kaufman JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY; Group for the Respect of Ethics and Excellence in Science (GREES). Lekkerkerker F, et al. Among authors: ethgen d. Osteoporos Int. 2007 Oct;18(10):1311-7. doi: 10.1007/s00198-007-0410-4. Epub 2007 Jun 22. Osteoporos Int. 2007. PMID: 17585359 Free article. Review.
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.
Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R. Reginster J, et al. Among authors: ethgen d. Osteoporos Int. 2000;11(1):83-91. doi: 10.1007/s001980050010. Osteoporos Int. 2000. PMID: 10663363 Clinical Trial.
Prevention of postmenopausal bone loss by tiludronate.
Reginster JY, Lecart MP, Deroisy R, Sarlet N, Denis D, Ethgen D, Collette J, Franchimont P. Reginster JY, et al. Among authors: ethgen d. Lancet. 1989 Dec 23-30;2(8678-8679):1469-71. doi: 10.1016/s0140-6736(89)92927-9. Lancet. 1989. PMID: 2574764 Clinical Trial.
25 results